Loading…
Atara Biotherapeutics, Inc. is projected to rise to $10.08 by 2027, a +20% move from its current price of $8.38. ATRA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $8.08 | $8.39 | $8.70 | +0.06% |
| Aug 6 | $7.96 | $8.39 | $8.84 | +0.12% |
| Aug 7 | $7.87 | $8.40 | $8.95 | +0.18% |
| Aug 8 | $7.80 | $8.40 | $9.05 | +0.24% |
| Aug 9 | $7.73 | $8.41 | $9.14 | +0.30% |
| Aug 10 | $7.68 | $8.41 | $9.21 | +0.36% |
| Aug 11 | $7.62 | $8.42 | $9.29 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.62 | $8.42 | $9.29 | +0.42% |
| Week 2 | $7.35 | $8.45 | $9.71 | +0.84% |
| Week 3 | $7.15 | $8.49 | $10.07 | +1.26% |
| Week 4 | $7.00 | $8.52 | $10.38 | +1.68% |
| Week 5 | $6.86 | $8.56 | $10.67 | +2.11% |
| Week 6 | $6.75 | $8.59 | $10.94 | +2.54% |
| Week 7 | $6.65 | $8.63 | $11.20 | +2.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of Epstein-Barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases.
It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases.
The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
The current price is $7.90 and the market capitalization is $71.18M. It ranks 4162.
The forecast suggests an improving long-term price trajectory with 2026 average $7.90, a 2026 min of $4.18 and max of $10.74, and overall sentiment NEUTRAL.
Longer-term, the forecast envisions upside with 2030 average price $12.09 (ROI 53%), 2040 average $24.66 (ROI 212.2%), and 2050 average $46.77 (ROI 492%).
Other intermediate years show continued movement, including 2027 average $8.67, 2029 average $9.40, and 2032–2035 bullish expansions.
A major floor 48.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.0% below — buyers have tended to step in here.
The nearest ceiling, 39.0% above — a clean break opens room to run.
A major ceiling 57.4% above — clearing it would confirm fresh momentum.
Key ATRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.03 | Buy | $8.16 | Buy |
| MA 10 | $8.12 | Buy | $8.26 | Buy |
| MA 20 | $8.71 | Sell | $8.66 | Sell |
| MA 50 | $9.65 | Sell | $8.88 | Sell |
| MA 100 | $7.77 | Buy | $8.66 | Sell |
| MA 200 | $9.42 | Sell | $9.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.50 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -31.08 | Neutral |
| Williams %R (14) | -33.66 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -1.99 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 66.34 | Neutral |
| TRIX (15) | -0.74 | Sell |
| Awesome (5,34) | -1.46 | Sell |
| Ultimate (7,14,28) | 53.58 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 8.13 | Buy |
| ADX (14) | 19.44 | Neutral |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 40.
The price is hovering around the 50-day simple moving average of $9.85 and the 200-day moving average of $9.64, suggesting a mild drift rather than a clear trend.
Support sits at $8.04 and resistance at $11.65. The 30-day price range runs from $5.96 to $10.47.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.18 | $8.38 | $11.33 | 0% | Neutral | |
| $7.77 | $10.08 | $13.97 | +20% | Bullish | |
| $7.01 | $9.46 | $13.76 | +13% | Neutral | |
| $8.78 | $12.25 | $18.51 | +46% | Bullish | |
| $11.55 | $16.61 | $25.90 | +98% | Bullish | |
| $12.53 | $18.52 | $29.66 | +121% | Bullish | |
| $13.93 | $21.11 | $34.65 | +152% | Bullish | |
| $14.03 | $21.80 | $36.55 | +160% | Bullish | |
| $14.15 | $22.49 | $38.48 | +168% | Bullish | |
| $15.05 | $24.47 | $42.65 | +192% | Bullish | |
| $22.76 | $41.04 | $77.20 | +390% | Bullish | |
| $40.17 | $87.43 | $183.47 | +943% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.18 | $8.38 | $10.15 | +0.00% |
| September 2026 | $7.34 | $8.77 | $10.84 | +4.63% |
| October 2026 | $7.33 | $8.85 | $11.10 | +0.92% |
| November 2026 | $7.11 | $8.64 | $10.96 | -2.35% |
| December 2026 | $7.22 | $8.84 | $11.33 | +2.32% |
Click any year to see its month-by-month ATRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATRA price prediction for 2026 points to an average of $8.38 (low $4.18, high $11.33) — a potential gain of 0% on today's $8.38. A consolidation phase looks the most probable path here.
In 2027, ATRA is projected to trade between $7.77 and $13.97, averaging $10.08 — a potential gain of +20% from today's $8.38. That is up +20% on the projected 2026 average. Momentum favours further upside here.
Atara Biotherapeutics, Inc.'s 2028 outlook centres on $9.46, within a $7.01 to $13.76 range. That is -6% versus the projected 2027 average. That marks a +13% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ATRA could reach as high as $18.51, with a base case around $12.25 and support toward $8.78 — roughly +46% from $8.38. Momentum favours further upside here.
Expect ATRA to range from $11.55 to $25.90 through 2030. The $16.61 average target implies a +98% move from current prices. That is up +36% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ATRA price prediction for 2031 points to an average of $18.52 (low $12.53, high $29.66) — a potential gain of +121% on today's $8.38. Momentum favours further upside here.
In 2032, ATRA is projected to trade between $13.93 and $34.65, averaging $21.11 — a potential gain of +152% from today's $8.38. That is up +14% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Atara Biotherapeutics, Inc.'s 2033 outlook centres on $21.80, within a $14.03 to $36.55 range. That is up +3% on the projected 2032 average. That marks a +160% change versus current levels. Momentum favours further upside here.
By 2034, ATRA could reach as high as $38.48, with a base case around $22.49 and support toward $14.15 — roughly +168% from $8.38. Buyers look set to stay in control over this stretch.
Expect ATRA to range from $15.05 to $42.65 through 2035. The $24.47 average target implies a +192% move from current prices. That is up +9% on the projected 2034 average. Momentum favours further upside here.
The ATRA price prediction for 2040 points to an average of $41.04 (low $22.76, high $77.20) — a potential gain of +390% on today's $8.38. Buyers look set to stay in control over this stretch.
In 2050, ATRA is projected to trade between $40.17 and $183.47, averaging $87.43 — a potential gain of +943% from today's $8.38. That is up +113% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ATRA today (≈ 119.331742 ATRA) could be worth
$10,433.51
+$9,433.51 (+943%) by 2050 · US Dollar
Based on the average projected ATRA price of $87.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATRAwould be worth at today's price.
$1,000 invested in ATRA on Jul 31, 2025 (≈ 86.805552 ATRA) would be worth
$727.43
-$272.57 (-27.3%) today · 0.73× · US Dollar
Based on a ATRA entry price of $11.52 vs. today's $8.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.9 | $1,060.76 | +6.1% |
| 1 month ago | $11.37 | $737.03 | -26.3% |
| 3 months ago | $4.9 | $1,710.2 | +71.0% |
| 6 months ago | $5.04 | $1,662.7 | +66.3% |
| 1 year ago | $11.52 | $727.43 | -27.3% |
| All time (5.0y) ago | $321.75 | $26.05 | -97.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATRA forecast.
Our base-case forecast reaches $17.00 around 2031.
Implied market cap at $17.00: $153.17M
The multi-year forecast shows meaningful upside from the current level. In 2030 the average forecast price is $12.09 with an ROI of 53%. The 2040 forecast projects an average of $24.66 with an ROI of 212.2%, and the 2050 forecast projects an average of $46.77 with an ROI of 492%.
Earlier years exhibit more modest or even negative moves, such as 2026 with an average of $7.90 and ROI of 0%, and 2028 with an average of $7.47 and ROI of -5.4%. The forecast also highlights strong upside in later years, including 2031 average $13.28 (ROI 68%), 2032 average $15.32 (ROI 93.9%), and 2035 average $15.95 (ROI 101.9%). Finally, the long-range view points to 2040 and 2050 as the most bullish, with $24.66 and $46.77 as averages and ROIs of 212.2% and 492%, respectively.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $12.09, a low of $8.09 and a high of $19.57, with a projected ROI of 53%.
Long-term forecasts show bullish momentum from 2030 onward, with 2030 average $12.09 and 2050 average $46.77, and ROIs rising to as high as 492% by 2050, though some years (e.g., 2028) show negative or flat returns.
The forecast max rises to $49.01 by 2040 and to $104.59 by 2050, indicating the possibility of surpassing $50 in the long term.
The 30-day range is from $5.96 to $10.47.
The current price is $7.90 and the market cap is $71.18M.
Atara Biotherapeutics, Inc. Community Discussion
0Share your Atara Biotherapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.